← Back to Search

Behavioural Intervention

Neofect RAPAEL Smart Glove for Stroke (vREHAB Trial)

N/A
Waitlist Available
Led By Kara Flavin, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

vREHAB Trial Summary

This trial will help assess whether or not a virtual reality biofeedback system can promote recovery of distal arm and hand function in stroke patients.

Eligible Conditions
  • Stroke

vREHAB Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improvement in Functional Impairment, Jebsen Taylor Hand Function Test
Secondary outcome measures
Improvement in Functional Impairment, Upper Extremity Fugl-Meyer assessment
Persistence of treatment effects from 12-24 weeks in Jebsen Taylor hand function test
Persistence of treatment effects from 12-24 weeks in Upper Extremity Fugl-Meyer test
+2 more

vREHAB Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Standard Occupational Therapy + Smart GloveExperimental Treatment1 Intervention
Subjects randomized to this arm will be expected to use the Neofect Rapael Smart Glove for a minimum of 20-30 minutes per day, 5 days per week, in addition to prescribed occupational therapy.
Group II: Standard Occupational TherapyActive Control1 Intervention
Subjects in the control arm will undergo standard of care occupational therapy as prescribed by their care team.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Neofect RAPAEL Smart Glove
2018
N/A
~50

Find a Location

Who is running the clinical trial?

NEOFECT Rehabilitation SolutionsOTHER
2 Previous Clinical Trials
100 Total Patients Enrolled
2 Trials studying Stroke
100 Patients Enrolled for Stroke
Stanford UniversityLead Sponsor
2,385 Previous Clinical Trials
17,333,816 Total Patients Enrolled
25 Trials studying Stroke
56,415 Patients Enrolled for Stroke
Kara Flavin, MDPrincipal InvestigatorStanford University
1 Previous Clinical Trials
20 Total Patients Enrolled
1 Trials studying Stroke
20 Patients Enrolled for Stroke

Media Library

Neofect RAPAEL Smart Glove (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03741400 — N/A
Stroke Research Study Groups: Standard Occupational Therapy + Smart Glove, Standard Occupational Therapy
Stroke Clinical Trial 2023: Neofect RAPAEL Smart Glove Highlights & Side Effects. Trial Name: NCT03741400 — N/A
Neofect RAPAEL Smart Glove (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03741400 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment ongoing for this trial?

"According to clinicaltrials.gov, this investigation is currently enrolling members. The trial was first launched on October 1st 2018 and the details were most recently revised on October 26th 2022."

Answered by AI

How many participants are currently being monitored in this trial?

"Affirmative. Clinicaltrials.gov offers evidence that this clinical trial is presently enrolling participants, with the original post being made on October 1st 2018 and last edited on October 26th 2022. Forty individuals are sought at one site for inclusion in the study."

Answered by AI

Who else is applying?

What state do they live in?
New York
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
~6 spots leftby Apr 2025